Jim Tananbaum is the founder as well as CEO of Foresite Capital. This company was founded in 2011 and is dedicated to healthcare. It helps to identify potential emerging leaders in this industry and then provides them with adequate resources to make them successful.
He is a math as well as electrical engineering/computer science major. He earned this from Yale. His M.D. and M.B.A. are from Harvard. He did his M.S. from the Massachusetts Institute of Technology. Jim Tananbaum was always passionate about complementing interdisciplinary hard sciences along with computer science as well as healthcare. He feels that we are entering into an era of great change. This would require developing insights into learning along with science.
Jim Tananbaum has over 25 years of experience in being an entrepreneur in healthcare besides being an investment strategist too. This is why he can easily identify the key factors that can enable entrepreneurs and companies to succeed. Most of these factors are based on innovation and the people who can make it happen.
Foresite Capital can understand the future of healthcare and has the ability to harness it well. Jim Tananbaum realizes that innovation in healthcare products would require much more time as well as capital than what most entrepreneurs expect.
According to Wired.com, this is why Foresite Capital can help emerging leaders by providing them relevant information along with networks, as well as capital that will help them to succeed. The company collects all the available published information. This helps it to know what is needed that will truly impact healthcare. Then they can determine the investment prospects that will be the most viable and have the highest probability of being successful.
Foresite Capital is presently investing in 77 different companies that are related to healthcare. The areas include biopharmaceuticals, besides medical services, as well as diagnostics along with genomic sequencing. The notable among these include 10x Genomics, besides Intarcia Therapeutics, and Aerie Pharmaceuticals along with Aimmune Therapeutics.
Tananbaum likes to spend most of his work day in meetings with other members of his team to discuss the company updates. He looks at new company presentations too.